Melanoma immunotherapy enabled by M2 macrophage targeted immunomodulatory cowpea mosaic virus.
Mater Adv
; 5(4): 1473-1479, 2024 Feb 19.
Article
in En
| MEDLINE
| ID: mdl-38380336
ABSTRACT
We have developed nanoparticle formulations targeting M2 macrophages for cancer immunotherapy by conjugating high-affinity binding peptides to cowpea mosaic virus as an immunostimulatory adjuvant. We confirmed the targeting of and uptake by M2 macrophages in vitro and the therapeutic efficacy of the nanoparticles against murine melanoma in vivo.
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Language:
En
Journal:
Mater Adv
Year:
2024
Document type:
Article
Country of publication: